Jul 26, 09:22 AM

Pfizer-BioNTech COVID-19 Vaccine Linked to 112,000% Increase in Brain Clots, 19,417 VAERS Deaths, and Excess Deaths in Japan

Recent studies and data analyses have raised concerns about adverse health events following COVID-19 vaccination, particularly with the Pfizer-BioNTech (BNT162b2) mRNA vaccine. Research published in medical journals such as PubMed, eClinicalMedicine, and the JMA Journal highlights potential links between COVID-19 vaccines and complications including thromboembolic events, hemorrhagic stroke, intracranial hemorrhage, neuropsychiatric conditions, and peripheral nervous system complications. A self-controlled case series study compared mRNA (BNT162b2) and inactivated (CoronaVac) vaccines regarding thromboembolic and hemorrhagic events. Additionally, a study from Japan reported an increase in excess deaths following repeated COVID-19 vaccinations. Analysis of the Vaccine Adverse Event Reporting System (VAERS) data by independent researchers indicated 19,417 deaths reported post-COVID vaccination. Further examination revealed a 112,000% increase in cerebral thrombosis reports after mRNA COVID-19 vaccines over three years compared to flu vaccines administered over 34 years. These findings have prompted scrutiny of CDC and FDA data handling and raised questions about the safety profile of COVID-19 vaccines, especially the mRNA formulations.

#PubMed #eClinicalMedicine #JMA Journal #Japan #CDC #FDA

Written with ChatGPT (GPT-4).

Pfizer-BioNTech COVID-19 Vaccine Linked to 112,000% Increase in Brain Clots, 19,417 VAERS Deaths, and Excess Deaths in Japan

Sources

Additional media

Similar Stories

Similar Stories